Compare Dr. Reddys with DESH RAKSHAK - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs DESH RAKSHAK - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB DESH RAKSHAK DR. REDDYS LAB/
DESH RAKSHAK
 
P/E (TTM) x 37.6 4.1 906.0% View Chart
P/BV x 4.0 0.2 1,957.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 DR. REDDYS LAB   DESH RAKSHAK
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
DESH RAKSHAK
Mar-21
DR. REDDYS LAB/
DESH RAKSHAK
5-Yr Chart
Click to enlarge
High Rs5,5154 128,546.6%   
Low Rs3,0284 77,629.5%   
Sales per share (Unadj.) Rs1,145.414.9 7,707.6%  
Earnings per share (Unadj.) Rs114.50.9 12,100.9%  
Cash flow per share (Unadj.) Rs188.41.5 12,226.8%  
Dividends per share (Unadj.) Rs25.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs1,053.219.8 5,312.8%  
Shares outstanding (eoy) m166.304.44 3,745.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.70.3 1,353.7%   
Avg P/E ratio x37.34.3 862.8%  
P/CF ratio (eoy) x22.72.7 853.7%  
Price / Book Value ratio x4.10.2 1,963.9%  
Dividend payout %21.80-   
Avg Mkt Cap Rs m710,28918 3,908,055.3%   
No. of employees `000NANA-   
Total wages/salary Rs m36,2998 466,568.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,47566 288,686.0%  
Other income Rs m2,9140 1,942,666.7%   
Total revenues Rs m193,38966 292,437.6%   
Gross profit Rs m38,69910 390,110.9%  
Depreciation Rs m12,2883 465,454.5%   
Interest Rs m9702 49,238.6%   
Profit before tax Rs m28,3555 518,372.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3191 733,779.5%   
Profit after tax Rs m19,0364 453,238.1%  
Gross profit margin %20.315.0 135.1%  
Effective tax rate %32.923.2 141.9%   
Net profit margin %10.06.4 156.9%  
BALANCE SHEET DATA
Current assets Rs m145,50356 261,601.9%   
Current liabilities Rs m81,03829 275,171.5%   
Net working cap to sales %33.839.7 85.3%  
Current ratio x1.81.9 95.1%  
Inventory Days Days6113 489.0%  
Debtors Days Days95213,804,481 0.0%  
Net fixed assets Rs m109,97991 121,068.9%   
Share capital Rs m83247 1,784.3%   
"Free" reserves Rs m174,31941 421,162.1%   
Net worth Rs m175,15188 198,990.0%   
Long term debt Rs m6,29929 21,728.2%   
Total assets Rs m255,482146 174,450.0%  
Interest coverage x30.23.8 800.5%   
Debt to equity ratio x00.3 10.9%  
Sales to assets ratio x0.70.5 165.5%   
Return on assets %7.84.2 185.9%  
Return on equity %10.94.8 227.7%  
Return on capital %16.26.4 254.3%  
Exports to sales %51.312.3 418.5%   
Imports to sales %18.10-   
Exports (fob) Rs m97,6998 1,207,651.4%   
Imports (cif) Rs m34,420NA-   
Fx inflow Rs m97,6998 1,207,651.4%   
Fx outflow Rs m34,4200-   
Net fx Rs m63,2798 782,187.9%   
CASH FLOW
From Operations Rs m35,7038 426,559.1%  
From Investments Rs m-22,660-13 179,414.1%  
From Financial Activity Rs m-2988 -3,725.0%  
Net Cashflow Rs m12,8584 344,718.5%  

Share Holding

Indian Promoters % 26.7 64.3 41.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 49.7 0.0 -  
FIIs % 27.4 0.0 -  
ADR/GDR % 11.5 0.0 -  
Free float % 61.8 35.7 172.9%  
Shareholders   242,376 2,357 10,283.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    



Today's Market

Sensex Sheds 581 Points, Nifty Ends Near 17,100; HCL Tech & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jan 27, 2022 03:36 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS